Utility of patch testing in patients with hypersen... [AIDS. 2002]

Cited by 1 PubMed Central article

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, et al. Proc Natl Acad Sci U S A. 2004 Mar 23; 101(12):4180-5. Epub 2004 Mar 15.

[Proc Natl Acad Sci U S A. 2004]

Abacavir (Ziagen®, Epzicom® (as a combination product containing Abacavir and Lamivudine), Trizivir® (as a combination product containing Abacavir, Lamivudine, and Zidovudine))
Abacavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by ...
Source: AHFS Consumer Medication Information

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.